TrialAnnals of oncology : official journal of the European Society for Medical Oncology2017

Re-treatment with radium-223: first experience from an international, open-label, phase I/II study in patients with castration-resistant prostate cancer and bone metastases.

O Sartor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.